Role of fibrinogen in trauma-induced coagulopathy

被引:178
|
作者
Fries, D. [1 ]
Martini, W. Z. [2 ]
机构
[1] Innsbruck Med Univ, Dept Gen & Surg Crit Care Med, A-6020 Innsbruck, Austria
[2] USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA
关键词
coagulation; transfusion; trauma; FACTOR-XIII ACTIVITY; DILUTIONAL COAGULOPATHY; HYDROXYETHYL STARCH; MAJOR TRAUMA; HYPOTHERMIA; CONCENTRATE; HEMOSTASIS; HEMORRHAGE; PREDICTOR; ACIDOSIS;
D O I
10.1093/bja/aeq161
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Coagulation defects related to severe trauma, trauma-induced coagulopathy (TIC), have a number of causal factors including: major blood loss with consumption of clotting factors and platelets, and dilutional coagulopathy after administration of crystalloids and colloids to maintain blood pressure. In addition, activation of the fibrinolytic system or hyperfibrinolysis, hypothermia, acidosis, and metabolic changes can also affect the coagulation system. All of these directly affect fibrinogen polymerization and metabolism. Other bleeding-related deficiencies usually develop later in massive bleeding related to severe multiple trauma. In major blood loss, fibrinogen reaches a critical value earlier than other procoagulatory factors, or platelets. The question of the critical threshold value is presently the subject of heated debate. A threshold of 100 mg dl(-1) has been recommended, but recent clinical data have shown that at a fibrinogen level of < 150-200 mg dl(-1), there is already an increased tendency to peri- and postoperative bleeding. A high fibrinogen count exerts a protective effect with regard to the amount of blood loss. In multiple trauma patients, priority must be given to early and effective correction of impaired fibrin polymerization by administering fibrinogen concentrate.
引用
收藏
页码:116 / 121
页数:6
相关论文
共 50 条
  • [31] Author Correction: Trauma-induced coagulopathy
    Ernest E. Moore
    Hunter B. Moore
    Lucy Z. Kornblith
    Matthew D. Neal
    Maureane Hoffman
    Nicola J. Mutch
    Herbert Schöchl
    Beverley J. Hunt
    Angela Sauaia
    Nature Reviews Disease Primers, 8 (1)
  • [32] Hemostatic Management of Trauma-Induced Coagulopathy
    Phillips, Janise B.
    Mohorn, Phillip L.
    Bookstaver, Rebecca E.
    Ezekiel, Tanya O.
    Watson, Christopher M.
    CRITICAL CARE NURSE, 2017, 37 (04) : 37 - 47
  • [33] Evolving science of trauma-induced coagulopathy
    Fort, Alexander C.
    Dudaryk, Roman
    INTERNATIONAL ANESTHESIOLOGY CLINICS, 2021, 59 (02) : 25 - 30
  • [34] EXPERIMENTALLY APPROACHING THE TRAUMA-INDUCED COAGULOPATHY
    Martini, Wenjun
    SHOCK, 2016, 46 (04): : 11 - 11
  • [35] Trauma-induced coagulopathy and treatment in Kosovo
    O'Sullivan, J
    O'Sullivan, M
    MILITARY MEDICINE, 2001, 166 (04) : 362 - 365
  • [36] TIME IS LIVE IN TRAUMA-INDUCED COAGULOPATHY\
    Goerlinger, K.
    SHOCK, 2012, 38 (04): : 30 - 31
  • [37] Advances in the understanding of trauma-induced coagulopathy
    Chang, Ronald
    Cardenas, Jessica C.
    Wade, Charles E.
    Holcomb, John B.
    BLOOD, 2016, 128 (08) : 1043 - 1049
  • [38] Animal models of trauma-induced coagulopathy
    Frith, Daniel
    Cohen, Mitchell J.
    Brohi, Karim
    THROMBOSIS RESEARCH, 2012, 129 (05) : 551 - 556
  • [39] Tranexamic acid and trauma-induced coagulopathy
    Takeshi Nishida
    Takahiro Kinoshita
    Kazuma Yamakawa
    Journal of Intensive Care, 5
  • [40] Trauma-induced coagulopathy [Traumainduzierte koagulopathie]
    Hanke A.A.
    Rahe-Meyer N.
    Der Unfallchirurg, 2014, 117 (2): : 95 - 98